Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Bullboard Posts
Comment by HCallahann44on Jan 22, 2020 1:56pm
217 Views
Post# 30584290

RE:RE:Ok found the bear case for ONCY on seeking alpha

RE:RE:Ok found the bear case for ONCY on seeking alphanot shorting at all...in fact own 15 K shares and trying to decide whether or not to add at these levels. This stock is out of my depth because I just don't know the industry...everything seems positive...but given the odds...it seems like even if everything is positive you could still lose big... 8 percent approval rate is silly low...and I am used to speculating on precious metals plays...Canadafan...In return for all the great info you have provided...I will give you a play from my own portfolio...Eurasian Royalty...ticker EMX...check out the chart for the last several years...its just getting started --one of their royalties alone is worth half a billion dollars...and they have many---just purchased 20 additional royalties yesterday...they have a done of cash they are looking to deploy and their strategic investments have returned an annualized 40 percent since inception...insiders are buying shares...what happens when this goofy ponzi scheme of a market collapses and the public rushes into metals stocks...royalty plays always get the highest premiums...full disclosure...I won 120 k shares...how much oncy do you own...just curious?
Bullboard Posts